209 related articles for article (PubMed ID: 1594587)
21. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
[TBL] [Abstract][Full Text] [Related]
22. [Immunotherapy of tumors expressing IGF-I].
Trojan J; Duc HT; Lafarge-Frayssinet C; Upegui-Gonzales LC; Swiercz B; Bismuth H; Hor F; Anthony D; Guo Y; Ilan J
C R Seances Soc Biol Fil; 1996; 190(1):165-9. PubMed ID: 8881277
[TBL] [Abstract][Full Text] [Related]
23. Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA.
Resnicoff M; Tjuvajev J; Rotman HL; Abraham D; Curtis M; Aiken R; Baserga R
J Exp Ther Oncol; 1996 Nov; 1(6):385-9. PubMed ID: 9414429
[TBL] [Abstract][Full Text] [Related]
24. Cyclic adenosine 3',5'-monophosphate inhibits insulin-like growth factor I gene expression in rat glioma cell lines: evidence for regulation of transcription and messenger ribonucleic acid stability.
Wang L; Adamo ML
Endocrinology; 2001 Jul; 142(7):3041-50. PubMed ID: 11416026
[TBL] [Abstract][Full Text] [Related]
25. Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model.
Shevelev A; Burfeind P; Schulze E; Rininsland F; Johnson TR; Trojan J; Chernicky CL; Hélène C; Ilan J; Ilan J
Cancer Gene Ther; 1997; 4(2):105-12. PubMed ID: 9080119
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
[TBL] [Abstract][Full Text] [Related]
27. Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor.
Lowe WL; Meyer T; Karpen CW; Lorentzen LR
Endocrinology; 1992 May; 130(5):2683-91. PubMed ID: 1572288
[TBL] [Abstract][Full Text] [Related]
28. Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells.
Zhu CJ; Li YB; Wong MC
J Neurosci Res; 2003 Oct; 74(1):60-6. PubMed ID: 13130506
[TBL] [Abstract][Full Text] [Related]
29. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.
Shapiro DN; Jones BG; Shapiro LH; Dias P; Houghton PJ
J Clin Invest; 1994 Sep; 94(3):1235-42. PubMed ID: 8083365
[TBL] [Abstract][Full Text] [Related]
30. Double-stranded RNA decreases IGF-I gene expression in a protein kinase R-dependent, but type I interferon-independent, mechanism in C6 rat glioma cells.
Chacko MS; Adamo ML
Endocrinology; 2002 Feb; 143(2):525-34. PubMed ID: 11796507
[TBL] [Abstract][Full Text] [Related]
31. The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo.
Pu P; Kang C; Li J; Jiang H; Cheng J
J Neurooncol; 2006 Jan; 76(1):1-11. PubMed ID: 16402276
[TBL] [Abstract][Full Text] [Related]
32. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation.
Pass HI; Mew DJ; Carbone M; Donington JS; Baserga R; Steinberg SM
Dev Biol Stand; 1998; 94():321-8. PubMed ID: 9776253
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA.
Ellouk-Achard S; Djenabi S; De Oliveira GA; Desauty G; Duc HT; Zohair M; Trojan J; Claude JR; Sarasin A; Lafarge-Frayssinet C
J Hepatol; 1998 Nov; 29(5):807-18. PubMed ID: 9833920
[TBL] [Abstract][Full Text] [Related]
34. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
[TBL] [Abstract][Full Text] [Related]
35. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
36. Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.
Chernicky CL; Yi L; Tan H; Ilan J
Clin Breast Cancer; 2005 Oct; 6(4):340-8. PubMed ID: 16277885
[TBL] [Abstract][Full Text] [Related]
37. Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-beta antisense gene.
Liau LM; Fakhrai H; Black KL
Neurol Res; 1998 Dec; 20(8):742-7. PubMed ID: 9864741
[TBL] [Abstract][Full Text] [Related]
38. Glucose stimulates IGF-I gene expression in C6 glioma cells.
Straus DS; Burke EJ
Endocrinology; 1995 Jan; 136(1):365-8. PubMed ID: 7828554
[TBL] [Abstract][Full Text] [Related]
39. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
